Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sascha Fauser

Showing results (171-180 of 237) with videos related to

Pageof 24
Sort By:
The Ocular Surface|May 9, 2025
Identification of a translatable animal model for dry eye disease using comparative analysis of tear proteins across speciesMayelín Pérez-Perdomo, Ana González-López, Laura Ortega-Llamas, et al.
JAMA Ophthalmology|December 6, 2016
The Functional Effect of Rare Variants in Complement Genes on C3b Degradation in Patients With Age-Related Macular DegenerationMaartje J Geerlings, Mariann Kremlitzka, Bjorn Bakker, et al.
Metabolites|June 27, 2023
Systemic Metabolomics in a Framework of Genetics and Lifestyle in Age-Related Macular DegenerationEric F Thee, İlhan E Acar, Johanna M Colijn, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 25, 2019
Patient characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakageThomas J van Rijssen, Elon H C van Dijk, Paula Scholz, et al.
American Journal of Ophthalmology|April 15, 2020
Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE TrialThomas J van Rijssen, Elon H C van Dijk, Paula Scholz, et al.
EMBO Molecular Medicine|December 23, 2016
Polysialic acid blocks mononuclear phagocyte reactivity, inhibits complement activation, and protects from vascular damage in the retinaMarcus Karlstetter, Jens Kopatz, Alexander Aslanidis, et al.
American Journal of Ophthalmology|November 14, 2020
Reply to Comment on: Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous ChorioretinopathyThomas J van Rijssen, Elon H C van Dijk, Greet Dijkman, et al.
Ophthalmology|March 26, 2019
Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized TrialJayashree Sahni, Sunil S Patel, Pravin U Dugel, et al.
Translational Vision Science & Technology|November 1, 2019
Modelling Macular Edema: The Effect of IL-6 and IL-6R Blockade on Human Blood-Retinal Barrier Integrity In VitroMarina Mesquida, Faye Drawnel, Philippa J Lait, et al.
Investigative Ophthalmology & Visual Science|July 21, 2012
Genetic, behavioral, and sociodemographic risk factors for second eye progression in age-related macular degenerationYara T E Lechanteur, Johannes P H van de Ven, Dzenita Smailhodzic, et al.
Pageof 24

Showing results (171-180 of 237) with videos related to

Sort By:
Pageof 24
The Ocular Surface|May 9, 2025
Identification of a translatable animal model for dry eye disease using comparative analysis of tear proteins across speciesMayelín Pérez-Perdomo, Ana González-López, Laura Ortega-Llamas, et al.
JAMA Ophthalmology|December 6, 2016
The Functional Effect of Rare Variants in Complement Genes on C3b Degradation in Patients With Age-Related Macular DegenerationMaartje J Geerlings, Mariann Kremlitzka, Bjorn Bakker, et al.
Metabolites|June 27, 2023
Systemic Metabolomics in a Framework of Genetics and Lifestyle in Age-Related Macular DegenerationEric F Thee, İlhan E Acar, Johanna M Colijn, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 25, 2019
Patient characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakageThomas J van Rijssen, Elon H C van Dijk, Paula Scholz, et al.
American Journal of Ophthalmology|April 15, 2020
Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE TrialThomas J van Rijssen, Elon H C van Dijk, Paula Scholz, et al.
EMBO Molecular Medicine|December 23, 2016
Polysialic acid blocks mononuclear phagocyte reactivity, inhibits complement activation, and protects from vascular damage in the retinaMarcus Karlstetter, Jens Kopatz, Alexander Aslanidis, et al.
American Journal of Ophthalmology|November 14, 2020
Reply to Comment on: Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous ChorioretinopathyThomas J van Rijssen, Elon H C van Dijk, Greet Dijkman, et al.
Ophthalmology|March 26, 2019
Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized TrialJayashree Sahni, Sunil S Patel, Pravin U Dugel, et al.
Translational Vision Science & Technology|November 1, 2019
Modelling Macular Edema: The Effect of IL-6 and IL-6R Blockade on Human Blood-Retinal Barrier Integrity In VitroMarina Mesquida, Faye Drawnel, Philippa J Lait, et al.
Investigative Ophthalmology & Visual Science|July 21, 2012
Genetic, behavioral, and sociodemographic risk factors for second eye progression in age-related macular degenerationYara T E Lechanteur, Johannes P H van de Ven, Dzenita Smailhodzic, et al.
Pageof 24